pyrroles has been researched along with Primary Myelofibrosis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Damsky, W; King, B; Peterson, D | 1 |
Apostolidou, E; Borthakur, G; Burger, I; Kantarjian, H; Thomas, D; Verstovsek, S | 1 |
Asatiani, E; El-Shami, K; Kantarjian, H; Parikh, SA; Schimmer, A; Verstovsek, S; Walsh, W; Winton, E | 1 |
Heinzl, S | 1 |
Hasselbalch, HC | 1 |
KIMBER, RJ; LANDER, H; ROBSON, HN | 1 |
1 review(s) available for pyrroles and Primary Myelofibrosis
Article | Year |
---|---|
[Janus kinase inhibitors as a new therapeutic principle].
Topics: Arthritis, Rheumatoid; Colitis, Ulcerative; Enzyme Inhibitors; Humans; Janus Kinases; Nitriles; Piperidines; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Pyrroles; Signal Transduction | 2012 |
2 trial(s) available for pyrroles and Primary Myelofibrosis
Article | Year |
---|---|
Phase II study of sunitinib in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis.
Topics: Aged; Antineoplastic Agents; Female; Humans; Indoles; Male; Middle Aged; Polycythemia Vera; Primary Myelofibrosis; Pyrroles; Sunitinib; Thrombocythemia, Essential | 2010 |
Phase II study of obatoclax mesylate (GX15-070), a small-molecule BCL-2 family antagonist, for patients with myelofibrosis.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Indoles; Male; Middle Aged; Primary Myelofibrosis; Proto-Oncogene Proteins c-bcl-2; Pyrroles | 2010 |
3 other study(ies) available for pyrroles and Primary Myelofibrosis
Article | Year |
---|---|
The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Topics: Arthritis, Rheumatoid; Azetidines; Betacoronavirus; Colitis, Ulcerative; Coronavirus Infections; COVID-19; Cytokines; Dermatitis, Atopic; Heterocyclic Compounds, 3-Ring; Humans; Immunomodulation; Janus Kinases; Nitriles; Pandemics; Piperidines; Pneumonia, Viral; Primary Myelofibrosis; Purines; Pyrazoles; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; SARS-CoV-2; STAT Transcription Factors; Sulfonamides | 2020 |
SU6668 in idiopathic myelofibrosis--a rational therapeutic approach targeting several tyrosine kinases of importance for the myeloproliferation and the development of bone marrow fibrosis and angiogenesis.
Topics: Bone Marrow; Enzyme Inhibitors; Humans; Indoles; Models, Biological; Neovascularization, Pathologic; Oxindoles; Primary Myelofibrosis; Propionates; Pyrroles; Receptor Protein-Tyrosine Kinases | 2003 |
THE SEQUESTRATION OF NEM-TREATED RED CELLS IN NORMAL AND ABNORMAL SUBJECTS: A TEST OF SPLENIC UPTAKE FUNCTION.
Topics: Anemia; Anemia, Hemolytic; Erythrocytes; Ethylmaleimide; Hodgkin Disease; Humans; Liver; Liver Cirrhosis; Pharmacology; Physiology; Prednisolone; Primary Myelofibrosis; Pyrroles; Spleen; Splenectomy; Splenomegaly | 1965 |